Daily Sepsis Research Analysis
Three impactful studies advance sepsis science and care pathways: (1) a deep learning model with conformal prediction enables accurate early sepsis diagnosis in non-ICU settings with external validation and fewer false alarms; (2) helminth-derived excretory/secretory proteins attenuate sepsis-induced myocardial dysfunction in mice via M2 macrophage polarization and HMGB1/TLR2/NF-κB pathway modulation; (3) the age-adjusted Charlson Comorbidity Index (ACCI) predicts 6-month mortality in older seps
Summary
Three impactful studies advance sepsis science and care pathways: (1) a deep learning model with conformal prediction enables accurate early sepsis diagnosis in non-ICU settings with external validation and fewer false alarms; (2) helminth-derived excretory/secretory proteins attenuate sepsis-induced myocardial dysfunction in mice via M2 macrophage polarization and HMGB1/TLR2/NF-κB pathway modulation; (3) the age-adjusted Charlson Comorbidity Index (ACCI) predicts 6-month mortality in older sepsis survivors discharged to skilled nursing facilities.
Research Themes
- Early sepsis detection using deep learning and uncertainty quantification
- Immunomodulatory therapeutics targeting sepsis-induced organ dysfunction
- Post-acute prognostication and care planning for sepsis survivors
Selected Articles
1. Time-series deep learning and conformal prediction for improved sepsis diagnosis in primarily Non-ICU hospitalized patients.
A time-series deep learning model with conformal prediction accurately predicted sepsis 6–24 hours before onset in non-ICU patients, with AUROCs up to 0.99 and a 57% reduction in false alarms on external validation. This approach supports early intervention and better resource allocation outside intensive care settings.
Impact: Introduces uncertainty-aware early sepsis prediction tailored to non-ICU settings with rigorous external validation, addressing a key implementation gap.
Clinical Implications: Hospitals could deploy the model to trigger earlier diagnostics and treatment in wards, potentially reducing ICU transfers and mortality; integration with EHRs and alert governance will be crucial.
Key Findings
- Achieved AUROCs of 0.96, 0.98, and 0.99 at 24, 12, and 6 hours before sepsis onset.
- Conformal prediction reduced false positives and improved specificity; external validation showed a 57% false alarm reduction at 6 hours.
- Model trained on 83,813 patients from MIMIC-IV and validated on eICU-CRD, demonstrating cross-setting generalizability.
Methodological Strengths
- Large-scale development with external validation across datasets
- Uncertainty quantification via conformal prediction to reduce false alarms
Limitations
- Retrospective EHR-based study without prospective clinical impact evaluation
- Generalizability beyond US datasets and alert fatigue in real-world workflows remain to be tested
Future Directions: Prospective, multi-center impact trials assessing clinical outcomes and workflow integration; fairness and subgroup performance analyses; calibration across EHR systems.
PURPOSE: Sepsis, a life-threatening condition from an uncontrolled immune response to infection, is a leading cause of in-hospital mortality. Early detection is crucial, yet traditional diagnostic methods, like SIRS and SOFA, often fail to identify sepsis in non-ICU settings where monitoring is less frequent. Recent machine learning models offer new possibilities but lack generalizability and suffer from high false alarm rates. METHODS: We developed a deep learning (DL) model tailored for non-ICU environments, using MIMIC-IV data with a conformal prediction framework to handle uncertainty. The model was trained on 83,813 patients and validated with the eICU-CRD dataset to test performance across hospital settings. RESULTS: Our model predicted sepsis at 24, 12, and 6 h before onset, achieving AUROCs of 0.96, 0.98, and 0.99, respectively. The conformal approach reduced false positives and improved specificity. External validation confirmed similar performance, with a 57 % reduction in false alarms at the 6 h window, supporting practical use in low-monitoring environments. CONCLUSIONS: This DL-based model enables accurate, early sepsis prediction with minimal data, addressing key clinical challenges and potentially improving resource allocation in hospital settings by reducing unnecessary ICU admissions and enhancing timely interventions.
2. Excretory/secretory proteins from Trichinella spiralis adult worms alleviate myocardial dysfunction induced by sepsis in murine models.
In a murine CLP sepsis model, intraperitoneal Ts-AES improved 72-hour survival (up to 40% vs. 0% in controls), enhanced systolic/diastolic function, and reduced myocardial injury and inflammation. Protection was associated with M2 macrophage polarization and suppression of HMGB1/TLR2/NF-κB signaling.
Impact: Demonstrates a novel helminth-derived immunomodulatory strategy that ameliorates sepsis-induced cardiomyopathy with mechanistic insights.
Clinical Implications: While preclinical, Ts-AES identifies a therapeutic pathway—macrophage reprogramming and HMGB1/TLR2/NF-κB blockade—that could inspire adjunctive treatments for sepsis-induced myocardial dysfunction.
Key Findings
- Ts-AES increased 72-hour survival in septic mice to about 40% versus 0% in untreated controls.
- Improved left ventricular systolic and diastolic function with reduced ventricular enlargement and myocardial injury.
- Mechanistically associated with M2 macrophage polarization and inhibition of HMGB1/TLR2/NF-κB signaling.
Methodological Strengths
- In vivo CLP model with functional, histological, and survival endpoints
- Mechanistic linkage to macrophage polarization and specific signaling pathway
Limitations
- Single-species, single-model preclinical study without dose-ranging or toxicity profiling
- Translational relevance to humans and long-term outcomes remain unknown
Future Directions: Dose-response and safety studies, replication in additional sepsis models, and exploration of Ts-AES components to inform translational development.
Sepsis-induced myocardial dysfunction (SIMD) is a hazardous symptom of sepsis and causes significant death rates. Although previous research has shown that helminthic derivatives alleviate disorders, the immunomodulatory functions of excretory/secretory proteins from Trichinella spiralis adult worms (Ts-AES) in SIMD have not yet been identified. We wanted to see how Ts-AES affects SIMD in this work and explore the potential immune mechanism involved. Murine sepsis model was established by cecal ligation and puncture (CLP) in male BALB/C mice. Following CLP surgery, each mouse received 20 μg Ts-AES intraperitoneally. Results showed that administration of Ts-AES improved the 72-h survival rate of septic mice by up to 40 % compared to untreated mice, who all died within the period. The SIMD was greatly alleviated, characterized by significantly improved left ventricle functions during systole and diastole, reduced biventricular enlargement, and myocardial injury scores. Upon histopathological examination, Ts-AES treatment greatly reduced cardiac inflammation and pathologic injury. The immunomodulatory effect of Ts-AES on protecting SIMD was associated with M2-type macrophage polarization that induces immunomodulatory cytokines and lowers pro-inflammatory cytokines, potentially by blocking the HMGB1/TLR2/NF-κB signal pathway. Our findings in this study demonstrate the potential of Ts-AES as a therapeutic agent for SIMD or other inflammatory disorders.
3. Older Adult Sepsis Survivors Discharged to Skilled Nursing Facilities: Age-Adjusted Charlson Comorbidity Index as a Predictor of 6-Month Mortality.
In 3,713 sepsis survivors aged ≥65 discharged to SNFs, each 1-point increase in ACCI increased 6-month mortality risk by 18%. ACCI stratified risk (HR 2.43 for high vs low) and outperformed SOFA (AUC 0.65 vs 0.53).
Impact: Provides a pragmatic, easily available prognostic tool for post-acute planning in a large, real-world cohort of older sepsis survivors.
Clinical Implications: ACCI can inform risk stratification at discharge to SNFs, guiding goals-of-care discussions, resource allocation, and targeted post-acute interventions.
Key Findings
- Each 1-point increase in ACCI was associated with an 18% higher 6-month mortality risk (HR 1.18).
- High ACCI (≥8) had HR 2.43 versus low (≤5); moderate group HR 1.55.
- ACCI outperformed SOFA in predicting 6-month mortality (AUC 0.65 vs 0.53).
Methodological Strengths
- Large cohort (n=3,713) with multivariable Cox modeling
- Direct comparison with SOFA and stratified risk groups
Limitations
- Observational, single-center dataset with potential residual confounding
- Calibration and net benefit analyses were not reported
Future Directions: External validation across health systems, integration into discharge workflows, and decision-curve analysis to quantify clinical utility.
BACKGROUND: Sepsis is a critical global health issue, particularly affecting older adults. Despite advances in acute sepsis management, the long-term outcomes for survivors, particularly those transitioning to skilled nursing facilities (SNFs), remain poorly characterized. AIM: To evaluate the prognostic value of the age-adjusted Charlson Comorbidity Index (ACCI) in predicting 6-month mortality among older adult sepsis survivors discharged to SNFs. STUDY DESIGN: An observational cohort study of older adult sepsis patients in the intensive care unit (ICU) of a tertiary academic medical centre in Boston from 2008 to 2019 was performed. Patients were stratified into low (≤ 5), intermediate (6, 7) and high (≥ 8) ACCI score groups. Using the Cox proportional hazards model, we determined the association between ACCI scores and 6-month mortality, calculating hazard ratios (HR) and 95% confidence intervals (CIs). The predictive performance was assessed using ROC curve analysis and compared with Sequential Organ Failure Assessment (SOFA) scores. RESULTS: The study included 3713 sepsis survivors aged 65 and older discharged to SNFs. The median age was around 80 years, and 52.6% of the participants were female. The analysis revealed that each one-point increase in the ACCI was associated with an 18% higher risk of mortality within 6 months (HR 1.18; 95% CI 1.14-1.22; p < 0.001). Furthermore, compared with individuals with low ACCI scores, those in the moderate ACCI score group had a HR of 1.55 (95% CI: 1.26-1.91, p < 0.001), and those in the high ACCI score group had a HR of 2.43 (95% CI: 1.96-3.03, p < 0.001). ACCI demonstrated superior predictive performance compared with SOFA scores (area under the curve [AUC] 0.65 vs. 0.53, p < 0.001). CONCLUSIONS: ACCI serves as an independent predictor of 6-month mortality in older adult sepsis survivors discharged to SNFs. RELEVANCE TO CLINICAL PRACTICE: Critical care nurses can use ACCI as a risk stratification tool to identify high-risk older sepsis survivors, inform discharge planning and improve interprofessional communication for tailored post-acute care interventions in SNFs.